|
CLINICAL AND EXPERIMENTAL OBSTETRICS AND GYNECOLOGY (ISSN 0390-6663) publishes
original work, preferably brief reports, in the fields of Gynecology,
Obstetrics, Fetal Medicine, Gynecological Endocrinology and related subjects.
(Fertility and Sterility, Menopause, Uro-gynecology, Ultrasound in Obstetrics
and Gynecology, Sexually Transmitted Diseases).The Journal is covered by INDEX
MEDICUS, MEDLINE, EMBASE/Excerpta Medica.
CLINICAL AND EXPERIMENTAL OBSTETRICS AND GYNECOLOGY is issued every three
months in one volume per year by IROG CANADA Inc. Montréal. Printed in Italy by
"La Garangola", Tipografia Editrice - Via E. Dalla Costa, 6 -35129 Padova
(Italy).
Clinical and Experimental Obstetrics and
Gynecology
http://www.irog.net/
General Information
CLINICAL AND EXPERIMENTAL OBSTETRICS AND GYNECOLOGY (ISSN 0390-6663) publishes
original peer-reviewed work, preferably brief reports, in the fields of
Gynecology, Obstetrics, Fetal Medicine, Gynecological Endocrinology, Fertility
and Sterility, Menopause, Uro-gynecology, Ultrasound diagnosis in Obstetrics
and Gynecology, Sexually transmitted diseases and related topics. It is indexed
in INDEX MEDICUS, MEDLINE, EMBASE/ Excerpta Medica.
AIMS AND SCOPE
Since its inception, the CLINICAL AND EXPERIMENTAL OBSTETRICS AND GYNECOLOGY
Journal has had the primary aim to assemble and diffuse scientific
researches, particularly original researches, contributions, reviews, and
proceedings of meetings in every field of the Discipline.
Today its large diffusion all over the world allows us to collect high quality
papers and clinical reports on many interesting studies from every country,
even from developing countries. This is the target goal of the Journal –
aiming at the diffusion of knowledge and advances in female genital diseases.
This publication tries to cover all aspects of obstetrics and gynecology in an
interdisciplinary approach among gynecologists, epidemiologists, pathologists,
oncologists, radiologists, microbiologists, surgeons, urologists,
neonatologists, genetists and so on.
The first target goal of the Journal is to publish high quality papers
in the shortest time possible. Research papers, editorial
reviews, case reports, technical notes, book reviews and letters to the Editor
are published.
ANNOUNCEMENTS regarding meetings,
postgraduate courses and symposia will be accepted 6 months before publication
and will be published free of charge.
BOOK SAMPLES for review should be sent to the
Editorial offices in Montréal or in Padova.
COPYRIGHT: the Journal has been registered with the
Copyright Clearance Center, Inc. Reproductions are not allowed without the
written consent of the Publisher. All photocopy fees should be paid to the
Copyright Clearance Center, Inc., 21 Congress Street, Salem, MA 01970, USA
stating the ISSN number, the volume and the first and last page numbers of each
article copied.
ADVERTISING INFORMATION: advertising orders and
inquiries may be sent to: I.R.O.G. CANADA Inc., Publisher, 4900 Côte St.
Luc, Apt. 212, Montréal (Quebec) Canada H3W 2HS, Tél.
514.4893242-4893640 - Fax 514.4854513 - E-mail:
canlux@mgroup-online.com - www.irog.net
RESPONSIBILITY: although every effort is made by the
editorial staff and the printer to eliminate misleading or inaccurate
information, the publisher accepts no responsibility for the consequences of
faultful or incorrect information. The authors recognize that the editor and
publisher have no responsibility and are indemnified against any liability or
claim that may result from the publication of misleading or incorrect data.
SUBSCRIPTION INFORMATION
The Journal is issued every three months (January, April, July and October);
one volume per year. Subscriptions start from January and are automatically
renewed if not cancelled by the end of September.
Subscriptions include four issues per year plus supplements and monographs and
all official communications of Meetings, Courses, Symposia and all scientific
activities in the fields of Obstetrics and Gynecology and related
topics.
Subscriptions are entered with prepayment only. The
annual subscription is $280 US for Institutions and $170 US for Individuals all
over the world. For air mail add $20. Single copies prepaid cost $75.00 US.
Send subscription requests with cheque or credit card payment (Amex - Visa -
Diners - Master Card) to I.R.O.G. CANADA Inc., 4900 Côte St. Luc, Apt.
212, Montréal, Québec H3W 2H3, Canada. Only US Funds are
accepted.
Claims for missing issues can be honored up to six
months. Changes of address: allow six weeks for all
changes to become effective. All communications should include both old and new
addresses (with postal codes) - better if accompanied by a mailing label from a
recent issue and should be sent to the printer La Garangola, Via E. Dalla
Costa, 6 - 35129 Padova (Italy) - also by Tel. +39.049.8075557, Fax
+39.049.7806580. Claims should be made within six months of publication date.
Duplicate copies will not be sent to replace those undelivered through failure
to notify of change of address.
Single copies and back issue and volume information is
available from the printer La Garangola, Padua, Tel. +39.049.8075557, Fax
+39.049.7806580. Certain back issues may only be available as photocopies of
the originals.
All other business correspondence including orders for offprints and
advertising space and any communication and requests should be addressed to
I.R.O.G. CANADA Inc., 4900 Côte St. Luc, Apt. 212, MONTRÉAL,
QUÉBEC H3W 2H3 (Canada), Tel. (514) 4893242, fax (514) 4854513.
IN ALL LEGAL MATTERS THE COURT OF MONTREAL IS COMPETENT.
Instructions to Authors
SUBMISSION OF MANUSCRIPTS
Papers should be submitted to A. ONNIS Editor-in-Chief of the EUROPEAN JOURNAL
OF GYNAECOLOGICAL ONCOLOGY, 4900 Côte St. Luc, Apt. 212 MONTREAL, QUÉBEC H3W
2H3 (Canada) - Tel. +514-4893242 - Fax +514-4854513, or Galleria Sto-rione 2/A
- 35123 PADOVA (Italy) - Fax +39-049-8752018.
Editorial articles for publication in the "Distinguished Expert Series" should
be submitted to P. Bösze, Editor-in-Chief of this section, Department of
Gynecology, Saint Stephan Hospital, 1096 Budapest, Nagyvárad tér 1, Telephone
(36-1) 275 2172, Fax (36-1)
275 2172, E-mail: bosze@axelero.hu
When a manuscript is submitted, an acknowledgement card is sent to the
corresponding author within two or three weeks.
Submitted papers are reviewed by the Editor-in-Chief and his Peer Referees.
Authors may be required to modify the manuscript according to the reviewers'
suggestions.
Manuscripts accepted for publication will be copyedited by the editorial staff
for typographical and grammatical mistakes and to guarantee clarity and
conciseness.
Publication time will be the shortest possible based on
scientific and publishing needs. Manuscripts submitted for publi-cation
cannot be returned.
Published papers will become property of the Journal and copyrighted under
I.R.O.G. CANADA Inc.
After six months no grievances will be accepted regarding published articles.
All statements are the responsibility of the authors. Product dosages,
indications and methods referred to in the papers reflect the author's
experience. No responsibility is assumed by the Editor-in-Chief or the
Publisher for any damage from use of any products, operation methods or
instructions contained in the published materials.
Trade names, trademarks, etc. are protected by the law and regulations. The
Editor-in-Chief and the Publisher cannot accept any legal responsibility for
any errors or omissions that may be made in press, particularly for information
about drug dosage and appli-cation thereof contained in the Journal. Consult
the prescribing information before administering any drug.
MANUSCRIPT REQUIREMENTS
The Journal follows the "Uniform requirements for manuscripts submitted to
biomedical journals" published in the New England Journal of Medicine 1991,
324, 424-8 and in the British Medical Journal 1991, 302.
Three manuscripts, typed and double spaced should be submitted
with an electronic disk, formatted in Word for Macintosh or Windows, version
6.0. Manuscripts without an electronic disk will not be accepted.
A cover letter signed by all authors must state that all authors who have
participated in the work take responsibility for the manuscript which has never
been pub lished or submitted for publication elsewhere. Without a
cover letter the publication will not be possible. Name, address and phone/fax
numbers of the Corresponding Author, responsible for revision and approval of
the proofs, should be indicated. Full-length articles should not exceed 8
printed pages including tables and references.
After the title page (full title and names of authors,
institutions, eventual acknowledgement for financial support, running title of
no more than 60 characters or spaces), original works should be arranged in the
conventional order: Summary (purpose of investiga-tion, methods, results,
conclusion - about 150 words), Key words, Content (a 20-word
summary), Introduction, Materials and Methods, Results, Discussion,
Conclusion, Acknowledgement (if any), References, Tables, Legends.
Authors should supply a complete address for reprint requests.
In the text only standard abbreviations can be used and must be avoided in the
title. The full term for which an abbreviation stands should precede its first
use in the summary and text unless it is a standard unit of measurement.
Authors must give their complete professional identifications
and affiliations, including all academic titles and positions.
Letters to the editor should be brief (500 words or less) and
offer objective, constructive and educational criticism of published material.
The editor reserves the right to publish.
Figures: Two original copies (not negatives) of each figure
are requested. Each figure should have a label on the back indicating its
number, author's name and top of the figure. Do not write on the back of the
figures and do not mount them on cardboard. If sending colour pictures
advise if they must be printed in colour or black and white (colour costs ten
times more).
Legends should be typed on a separate page with Arabic
numerals corresponding to the illustrations.
Tables should be titled, typed in double space on separate
pages and numbered in Arabic numerals in the order of their first cita-tion
in the text. Do not use internal rules. Only standard, universally understood
abbreviations should be used.
References should be numbered consecutively in the order in which they are
first mentioned in the text. Identify references in the text,
tables, and legends by Arabic numerals in parentheses.
Use the style of the examples below, which are based with slight modifications
on the format used by the U.S. National Library of Medicine in Index Medicus.
The titles of journals should be abbreviated according to the style used in
Index Medicus.
References must be verified by the Author(s) against the original documents.
Examples of correct forms of references are given below:
Articles in Journals: Authors' surname and initials (if more
than six names, give six followed by "et al."), Title, Abbreviated Journal
Title, Year of Publication, Volume, Issue and first page.
Books: Authors' surname and initials, title of the book and
title of chapter, in: Title, Editor(s), Place, Publisher, Year, Page.
Acknowledgments will be limited to appropriate professionals who
were contributors to the paper.
PROOFS revised by the editorial staff will be sent
to the corresponding author and should be checked and returned within ten days.
The corresponding author is responsible for detecting typesetting errors. After
this deadline the proofs will be considered approved. Only essential
corrections should be made; extensive changes will be charged to the authors.
BUSINESS MATTERS
The Journal has no commercial advertisements.
Authors will be expected to contribute to the printing expenses, tables,
figures and postage. For every published article a copy of the
Journal will be provided free of charge. Only payments in US dollars will
be accepted. No bank transfers.
Reprints should be requested with the form enclosed with the
acceptance letter. No free reprints will be supplied.
© By I.R.O.G. CANADA INC. - Publisher - Editorial office 4900
Côte St. Luc - Apt. 212 - Montréal Québec H3W 2H3 (Canada) - Tel. (514)
4893242-4893640 -Fax (514) 4854513 - Printed in Italy by "La Garangola" - Via
E. Dalla Costa, 6 - 35129 Padua (Italy) - Responsible Director: Prof. Antonio
Onnis M.D. - Authorization of Padua's Court n. 633 - 28-6-1979
|
| |
 Clinical
and Experimental Obstetrics & Gynecology - Vol. XXXVI, n. 3, 2009 |
| ORIGINAL ARTICLES |
|
| Reproductive Biology Section |
|
| Failure to have menses following progesterone withdrawal in a normal estrogenic woman with polycystic
ovarian syndrome who menstruates with oral contraceptives |
141 |
J.H. Check, J. Mitchell-Williams - Camden, NJ (USA)
Very high-bound testosterone levels despite normal free testosterone levels may have competed with estrogen and thus inhibited endometrial development resulting in failure to menstruate after progesterone withdrawal in a normal estrogenic woman
with polycystic ovarian syndrome. |
|
| Donor-recipient pairs to evaluate the effect of day 3 embryos having at least six blastomeres on pregnancy outcome |
143 |
J.H. Check, C. Dietterich, B. Katsoff, J.K. Choe, J. Amui - Camden, NJ (USA)
By evaluating donor egg recipient pairs the importance of an embryo having at least six blastomeres to improve the chance of implanting was confirmed. |
|
| Effects of endometrial thickness and echogenic pattern on assisted reproductive treatment outcome |
145 |
A. Çorbacıoglu, B. Baysal - Istanbul, TURKEY
The effects of endometrial thickness and echogenic pattern on pregnancy and implantation rates in ART cycles were investigated. |
|
| The effect of cetrorelix vs ganirelix on pregnancy outcome using minimal gonadotropin stimulation in
women with elevated day 3 serum follicle stimulating hormone levels |
148 |
J.H. Check, D. Brasile, J.K. Choe, J. Amui, C. Wilson - Camden, NJ (USA)
A trend for lower pregnancy rates following embryo transfer was seen when ganirelix was used as the GnRH antagonist compared to cetrorelix in women with diminished egg reserve. |
|
| Conventional oocyte insemination may result in a better pregnancy outcome than intracytoplasmic
sperm injection (ICSI) for unexplained infertility |
150 |
J.H. Check, A. Bollendorf, D. Summers-Chase, D. Horwath, W. Hourani - Camden, NJ (USA)
For couples with unexplained infertility, despite theoretical advantages of in vitro fertilization with intracytoplasmic sperm
injection (ICSI), conventional oocyte insemination results in significantly higher pregnancy rates. |
|
| Comparison of the efficacy of selecting sperm with normal nuclei by high magnification for intracytoplasmic sperm injection (ICSI) according to age in refractory in vitro fertilization (IVF) cases |
152 |
J.H. Check, D. Horwath, L. Sansoucie, D. Summers-Chase, W. Yuan - Camden, NJ (USA)
The isolation of sperm based on nuclear characteristics followed by intracytoplasmic sperm injection resulted in encouraging
pregnancy rates in women with several previous in vitro fertilization failures. |
|
| Successful pregnancy with frozen embryo transfer into a gestational carrier from eggs obtained from a
woman in premature menopause |
154 |
J.H. Check, M. Srivastava, D. Brasile, J. Amui, J.K. Choe, E. Dix - Camden, NJ (USA)
The first successful delivery is reported from a frozen embryo transfer derived from an egg developed in a woman with premature menopause. |
|
| General Section |
|
| Patient compliance with colposcopy information leaflets |
158 |
T. O’Gorman, S. Sivarajan, T. Hollingworth - London, UK
Patient satisfaction and understanding of information in leaflets does not result in compliance irrespective of language and
modification of leaflets. |
|
| Analysis of federal process of care data reported from hospitals in rural westernmost North Carolina |
160 |
E.S. Sills, B.A. Lotto, W.S. Bremer, A.J. Bacchi, A.P.H. Walsh - New York, NY (USA)
Data are analysed from three rural hospitals to determine performance with respect to state and national reference groups. |
|
| Role of a non-hormonal oral anti-fibrinolytic hemostatic agent (tranexamic acid) for management of
patients with dysfunctional uterine bleeding |
163 |
M. Gultekin, K. Diribas, E. Buru, M.A. Gökçeoglu - Çankiri, TURKEY
Oral tranexamic acid is a reasonable treatment option for patients with excessive dysfunctional perimenopausal bleeding with a
66% response rate. |
|
| Disturbed sleep and preterm birth: A potential relationship? |
166 |
L.B. Strange, K.P. Parker, M.L. Moor, O.L. Strickland, D.L. Bliwise - Atlanta, GA (USA)
In a study exploring the relationship between disturbed sleep and preterm birth, sleep latency was significantly associated with
preterm delivery. |
|
| Albumin/creatinine ratio for prediction of 24-hour albumin excretion of ≥ 2 g in manifest preeclampsia |
169 |
| R.A. Al, B. Borekci, O. Yapca, S. Keles, S. Kadanali - Erzurum, TURKEY
Random urine or 8-hour urine albumin-creatinine ratios are poor predictors for 24-hour albumin excretion of ≥ 2 in patients
with preeclampsia.
|
|
| Mid-trimester maternal serum hCG levels in predicting adverse pregnancy outcome |
173 |
G. Androutsopoulos, P. Gkogkos, P. Vassilakos, G. Panayiotakis, G. Decavalas - Rion, GREECE
Mid-trimester maternal serum hCG levels in predicting adverse pregnancy outcome. |
|
| An objective method to determine corneal changes during menopause |
176 |
N. Keskin, S. Cantürk, S. Aydin, H. Saygili, C. Özgün - Kutahya, TURKEY
Central corneal thickness (CCT) differences between women in the premenopausal and postmenopausal period were evaluated. The data suggest that menopause causes corneal changes which can be documented by CCT measurement. |
|
| Effectiveness of transvaginal colporrhaphy with porcine acellular collagen matrix in the treatment of
moderate to severe cystoceles |
179 |
G. Koutsougeras, P. Nicolaou, D. Karamanidis, G. Chimonis, A. Byros, E. Hatzopoulos - Alexandroupolis,
GREECE
Ninety-five patients with cystocele underwent anterior colporrhaphy using porcine dermal. After 12 months of postoperative
follow-up, the overall failure rate was 8.4%. |
|
| Uterine myoma in pregnancy: report of 19 patients |
182 |
E. Ozturk, M.G. Ugur, H. Kalayci, O. Balat - Gaziantep, TURKEY
Neither enlargement of myomas nor serious perinatal complications were observed in a prospective evaluation of 19 pregnant
women with uterine myoma. |
|
| Perceived pain and anxiety before and after amniocentesis among pregnant Turkish women |
184 |
R.A. Al, S. Yalvac, O.Y. Altar, I. Dolen - Erzurum, TURKEY
Perceived pain and anxiety were significantly and positively correlated to each other, and both decreased after the amniocentesis procedure. |
|
 |
|
| CASE REPORTS |
|
| Ectopic pelvic spleen. Presentation of two cases |
187 |
A. Liapis, K. Bakalianou, N. Salakos, C. Iavazzo, G. Paltoglou, A. Kondi-Pafiti - Athens, GREECE
Two cases of ectopic pelvic spleen accurring in young nulliparous women are described. |
|
| Sympathomimetic amine therapy may markedly improve treatment resistant headaches related to a vascular permeability defect common in women - presentation of two cases |
189 |
J.H. Check, D. Check, R. Cohen - Camden, NJ (USA)
Women with treatment refractory headaches should be evaluated for the condition of idiopathic edema by water load testing
because they may dramatically respond to treatment with dextroamphetamine sulfate. |
|
| Extrauterine pregnancy resulting from late spontaneous rupture of an unscarred gravid uterus: case
report |
192 |
N. Thomakos, K. Kallianidis, Z. Voulgaris, P. Drakakis, N. Arefetz, A. Antsaklis - Athens, GREECE
Extrauterine abdominal pregnancy is a rare entity associated with high maternal and perinatal mortality. |
|
|